How to buy AFT Pharmaceuticals (AFP) shares

Learn how to easily invest in AFT Pharmaceuticals shares.

AFT Pharmaceuticals Limited
AU: AFP - AUD
DRUG MANUFACTURERS-SPECIALTY & GENERIC
A$4.35
-

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

AFT Pharmaceuticals Limited is a drug manufacturers-specialty & generic business based in Australia. AFT Pharmaceuticals shares (AFP) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. AFT Pharmaceuticals has a trailing 12-month revenue of around $113.1 million. If you're looking to buy shares, check out the steps below.

How to buy shares in AFT Pharmaceuticals

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for AFT Pharmaceuticals. Find the share by name or ticker symbol: AFP. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until AFT Pharmaceuticals reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of AFT Pharmaceuticals. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

AFT Pharmaceuticals stock price (ASX:AFP)

Use our graph to track the performance of AFP stocks over time.

AFT Pharmaceuticals shares at a glance

Information last updated 2021-07-22.
52-week range$3.64 - $5.25
50-day moving average $4.2817
200-day moving average $4.3085
Target priceN/A
PE ratio 64.9254
Dividend yield N/A (0%)
Earnings per share (TTM) $0.067

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Name Product Standard brokerage fee Inactivity fee Markets
IG Share Trading
Finder Award
IG Share Trading
AUD $8 or 0.1%
$50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Superhero share trading
AUD $5
No
ASX shares, US shares, ETFs
Australia’s lowest-cost broker for ASX shares and ETFs.
Pay zero brokerage on US stocks and all ETFs and just $5 (flat fee) to trade Australian shares from your mobile or desktop.
CMC Markets Stockbroking
AUD $11 or 0.1%
No
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
Bell Direct Share Trading
Finder AwardExclusive
Bell Direct Share Trading
AUD $15
No
ASX shares, mFunds, ETFs
⭐ Finder Exclusive: Get 5 free stock trades and unlimited ETF trades until July 31, 2021 when you join Bell Direct.
Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.
Saxo Capital Markets (Classic account)
AUD $6.99
No
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs
Acess 19,000+ stocks on 37 exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
loading

Compare up to 4 providers

Is it a good time to buy AFT Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

AFT Pharmaceuticals price performance over time

Historical closes compared with the last close of A$4.59

1 month (2021-06-25) 9.29%

Is AFT Pharmaceuticals under- or over-valued?

Valuing AFT Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AFT Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

AFT Pharmaceuticals's P/E ratio

AFT Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 65x. In other words, AFT Pharmaceuticals shares trade at around 65x recent earnings.

That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

AFT Pharmaceuticals's EBITDA

AFT Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $11 million.

The EBITDA is a measure of a AFT Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.

AFT Pharmaceuticals financials

Revenue TTM $113.1 million
Operating margin TTM 9.47%
Gross profit TTM $48.7 million
Return on assets TTM 6.97%
Return on equity TTM 28.91%
Profit margin 6.88%
Book value 0.35
Market capitalisation $455.2 million

TTM: trailing 12 months

AFT Pharmaceuticals share dividends

We're not expecting AFT Pharmaceuticals to pay a dividend over the next 12 months.

AFT Pharmaceuticals share price volatility

Over the last 12 months, AFT Pharmaceuticals's shares have ranged in value from as little as $3.64 up to $5.25. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while AFT Pharmaceuticals's is 0.1714. This would suggest that AFT Pharmaceuticals's shares are less volatile than average (for this exchange).

AFT Pharmaceuticals overview

AFT Pharmaceuticals Limited develops, licenses, distributes, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail and oral care, pain management, skin care, and other products, as well as supplements. The company was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site
Not sure what platform to go with?
Take this quick quiz to find the right share trading platform